Did you know there’s even more we can do to promote your episode? Find out more…
Episode 118
Q123 M&A roundtable
Ross Burn, James Hales & Tom Cowap
/ CatSci, NorthEdge and Baird
In this special episode of Molecule to Market we have a roundtable with Ross Burn (CatSci), James Hales (NorthEdge) & Tom Cowap (Baird) discussing M&A’s
Episode 117
Meet the future of bioreactors
Will Patrick
/ Culture Biosciences
Will Patrick joins the podcast to discuss his experiences within the biopharma industry, cost savings for CDMOs, and much more.
Episode 116
Meet the lean, keen biotech
Ian Walters
/ Portage Biotech
Ian Walters joins the Molecule to Market podcast to discuss his new lean biotech that is keen to make break the traditional mold for biotechs.
Episode 115
Why biotechs are feeling the bite
Allan Shaw
/ CFO, Special Advisor & Board Member
Listen to Allan Shaw’s episode, covering his view on how the market is performing in the current economic climate to investment tips for biotechs.
Episode 114
The Amalgamator of Biz and Bio
Oren Beske
/ ATUM
Listen to Dr. Oren Beske’s episode, covering the journey from pre-clinical transactional deals to powering outsourcing for biotechs, and more.
Episode 113
The 30-year biotech and CDMO entrepreneur
Derek Hennecke
/ Entrepreneur and Board Member
Derek Hennecke discusses his acquisition journey, as well as how he thinks abour private equity and venture capital investment.
Episode 112
The ATMP and CDMO dealmaker
David Anderson
/ Ampersand Capital Partners
David Anderson dives into M&A insights in the life science outsourcing space, incluing including Brammer Bio’s sale to Thermo, and more.
Episode 111
From AZ to CRO Founder
Paul Dickinson
/ Seda Pharmaceutical Development Services
Paul Dickinson talks about how to master fast development programs, identifying poorly served niches in the CDMO/CRO space, and more.
Episode 110
The iterative nature of emerging therapeutics
Jennifer Chadwick
/ ProtaGene
Jennifer Chadwick joins us to talk about theraputic drugs, cell & gene therapy, risk-based assessment in early-stage drug development, & more
Episode 109
Think Star Trek, Think Smart Labs
Henal Shah
/ Cognizant
Listen to Henal Shah discuss life science industry trends, smart labs of the future, digital transformation, and more.
